SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001739614-24-000006
Filing Date
2024-02-28
Accepted
2024-02-28 09:10:06
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K inbx-20231231.htm   iXBRL 10-K 2352977
2 EX-10.15 elpisciencelicenseterminat.htm EX-10.15 68209
3 EX-23.1 exhibit231q42023.htm EX-23.1 2362
4 EX-31.1 exhibit311q42023.htm EX-31.1 10296
5 EX-31.2 exhibit312q42023.htm EX-31.2 10306
6 EX-32.1 exhibit321q42023.htm EX-32.1 5080
7 EX-32.2 exhibit322q42023.htm EX-32.2 5077
13 inbx-20231231_g1.jpg GRAPHIC 42549
14 inbx-20231231_g2.jpg GRAPHIC 166858
15 inbx-20231231_g3.jpg GRAPHIC 162808
16 inbx-20231231_g4.jpg GRAPHIC 24638
17 inbx-20231231_g5.jpg GRAPHIC 32638
18 inbx-20231231_g6.jpg GRAPHIC 36406
19 inbx-20231231_g7.jpg GRAPHIC 25254
20 inbx-20231231_g8.jpg GRAPHIC 451407
21 inbx-20231231_g9.jpg GRAPHIC 487913
  Complete submission text file 0001739614-24-000006.txt   11977880

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inbx-20231231.xsd EX-101.SCH 53985
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inbx-20231231_cal.xml EX-101.CAL 75426
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inbx-20231231_def.xml EX-101.DEF 246192
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inbx-20231231_lab.xml EX-101.LAB 711864
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inbx-20231231_pre.xml EX-101.PRE 465955
89 EXTRACTED XBRL INSTANCE DOCUMENT inbx-20231231_htm.xml XML 786062
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39452 | Film No.: 24690538
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)